hypertrophic cardiomyopathy: A condition in which the myocardium is hypertrophied without an obvious cause. The hypertrophy is generally asymmetric and may be associated with obstruction of the ventricular outflow tract.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
---|---|
Phenotype data |
473681 |
1. Apply sex-specific ruleNone |
473681 |
2. Check conditionsNone |
473681 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
634 |
4. Check minimum number of eventsNone |
634 |
5. Include endpointsNone |
634 |
6. Filter based on genotype QC (FinnGen only) |
608 |
Control definitions (FinnGen only)
Extra metadata
Similar endpoints
↥List of similar endpoints to Cardiomyopathy, Hypertrophic obstructive based on the number of shared cases.
Similar with more cases:
- Cardiomyopathy (excluding other)
- Cardiomyopathy
- Other heart diseases
- Other heart diseases
- Cardiovascular diseases (excluding rheumatic etc)
Similar with less cases:
None
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | |||
Whole population | 5095 | 2157 | 2870 |
Only index persons | 3542 | 1521 | 2021 |
Unadjusted period prevalence (%) | |||
Whole population | 0.07 | 0.06 | 0.08 |
Only index persons | 0.07 | 0.06 | 0.08 |
Median age at first event (years) | |||
Whole population | 59.89 | 63.64 | 56.99 |
Only index persons | 58.98 | 62.46 | 56.35 |
-FinnGen-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 608 | 255 | 353 |
Unadjusted period prevalence (%) | 0.14 | 0.10 | 0.18 |
Median age at first event (years) | 58.50 | 58.86 | 58.24 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Mortality – FinRegistry
↥Association
Association between endpoint I9_CARDMYOHYP and mortality.
Females
Parameter | HR [95% CI] | p-value |
---|---|---|
I9_CARDMYOHYP | 2.125 [1.83, 2.47] | < 0.001 |
Birth year | 0.993 [0.98, 1.0] | 0.105 |
During the follow-up period (1.1.1998 — 31.12.2019), 446 out of 1326 females with I9_CARDMYOHYP died.
Males
Parameter | HR [95% CI] | p-value |
---|---|---|
I9_CARDMYOHYP | 2.113 [1.81, 2.47] | < 0.001 |
Birth year | 0.988 [0.98, 1.0] | 0.012 |
During the follow-up period (1.1.1998 — 31.12.2019), 581 out of 1732 males with I9_CARDMYOHYP died.
Mortality risk
Mortality risk for people of age
years, who have I9_CARDMYOHYP.N-year risk | Females | Males |
---|---|---|
1 | 0.224% | 0.382% |
5 | 1.246% | 2.525% |
10 | 3.069% | 6.487% |
15 | 5.663% | 11.863% |
20 | 9.796% | 20.165% |
Relationships between endpoints
↥Index endpoint: I9_CARDMYOHYP – Cardiomyopathy, Hypertrophic obstructive
GWS hits: 14